Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research

Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research


According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.



from Biotech News